Therapeutic areas
With the overall aim of increasing patient engagement to life-changing treatment and medication, our focus is on long-term conditions, cancer, and rare diseases.
Our mission is to give patients control of their health through knowledge, choice, convenience and connection
Rare diseases & orphan drugs
We’re a global network dedicated to getting rare and orphan medicines to hard-to-reach patients worldwide.
Sciensus Digital+
We elevate patient care by combining advanced digital platforms with a personalised “human touch”.
Long-term conditions
As a leading pharma services organization, we help those with long-term conditions get the best from their medicines.
Cancer treatments
Delivering a range of treatments, we are the UK’s leading provider of cancer in-home care.
Delivering vital medicines
Cancer care at home
Increasing global access
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
Blogs
Strategic timing: When should biotech firms consider launching expanded access programs?
Expert shares his insights on when to launch expanded access programs in line with the regulatory landscape As the landscape…
Blogs
How to set up an EAP without a European presence
Demand for access to unlicensed medications for rare diseases is growing thanks to strong clinical trial data, greater awareness of…
Blogs
Sciensus announces two new senior hires as it continues to grow as a leading European life sciences organisation
Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that…